News
-
The FDA has announced the approval of Perrigo’s ANDA for a generic of Teva’s ProAir HFA albuterol MDI for the treatment of asthma in patients 4 years old and older. Perrigo initially filed its ANDA for… Read more . . .
-
United Therapeutics has announced that the Phase 3 INCREASE study of Tyvaso treprostinil inhalation solution for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD) met its primary endpoint, demonstrating statistically significant improvement in six-minute… Read more . . .
-
The FDA has approved Teva’s ArmonAir Digihaler fluticasone propionate DPI for the treatment of asthma in patients aged 12 and older, the company said. ArmonAir Respiclick was approved for that indication in January 2017. Three doses… Read more . . .
-
Aradigm Corporation, which filed for bankruptcy in February 2019, said that it will sell all of its assets related to Lipoquin inhaled ciprofloxacin, Apulmiq (Linhaliq) dual release inhaled ciprofloxacin, and other inhaled ciprofloxacin candidates to… Read more . . .
-
Nanopharm CEO Jag Shur has announced the addition of three new members of the company’s management team in a LinkedIn post. The new hires include two OINDP experts: Dave Farrow, who joins the company as… Read more . . .
-
Breath Therapeutics, which was acquired by Zambon in July 2019, said that it has initiated two new trials of its liposomal cyclosporine A for inhalation (L-CsA-i) for the treatment of bronchiolitis obliterans syndrome (BOS). BOSTON-3… Read more . . .
-
OINDP experts will gather once again in Palm Desert, California from April 26-30 for the 2020 edition of the Respiratory Drug Delivery (RDD) conference. As with past RDD meetings, attendees will find a scientific program… Read more . . .
-
Copley Scientific has announced the launch of a new inhaled dissolution dose collector (IDDC) system for the collection of representative samples of particles from MDIs and DPIs for dissolution testing by USP Method 2. The… Read more . . .
-
Training device and patient onboarding company Noble International, which was acquired by Aptar Pharma in October 2019, has announced the appointment of Jeffrey Miller as Director, Business Development. The company manufactures training devices that mimic… Read more . . .
-
Seurat Therapeutics has published data from studies of its intranasal IGF-1 in rat models for the treatment of migraine in the journal Brain Research. The studies were conducted at the University of Chicago, which has… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.